List view / Grid view
18 May 2012 | By Daiichi Sankyo
ArQule and Daiichi Sankyo announced that recruitment of patients has been completed...
17 May 2012 | By Novartis
Results from pivotal Phase III GLOW2 study...
17 May 2012 | By Teva Pharmaceutical Industries Ltd
“Dr. Phillip Frost has the Board’s full support..."
16 May 2012 | By Amgen
Updated results from a Phase 2 study...
16 May 2012 | By GlaxoSmithKline
GSK and Theravance, Inc. announced that following approval by Theravance...
16 May 2012 | By Catalent Pharma Solutions
“This competition allows us to acknowledge some of the world’s best emerging talent..."
16 May 2012 | By Roche
Phase III data on Avastin in advanced colorectal and ovarian cancers...
16 May 2012 | By Amgen
Exploratory biomarker analysis results...
Avalanche Biotechnologies, Inc., a leader in the area of long-term protein delivery for ocular diseases, and Lonza, a global leader in the field of biologics manufacturing, today announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy.
16 May 2012 | By Sanofi
Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured...
15 May 2012 | By Bristol-Myers Squibb Company
Expansion of Together on Diabetes® initiative to China and India ...
15 May 2012 | By kdm communications limited
Syrris, has developed the fast, flexible and accurate Asia Heater...
15 May 2012 | By Pfizer
Pfizer Inc announced that the Phase 3 INTORSECT study...
15 May 2012 | By GlaxoSmithKline
GSK to further expand its platform technology expertise with acquisition of chemical proteomics company...
15 May 2012 | By Bristol-Myers Squibb Company
State-of the art Manufacturing Facility Supports Company’s Growing Focus on Biologics...
